White CR - Search Results

1

Peptides as Therapeutic Agents for Atherosclerosis.

White CR, Palgunachari M, Wolkowicz P, Anantharamaiah GM. White CR, et al. Methods Mol Biol. 2022;2419:89-110. doi: 10.1007/978-1-0716-1924-7_6. Methods Mol Biol. 2022. PMID: 35237960

2

Apolipoprotein Mimetic Peptides as Modulators of Lipoprotein Function.

Anantharamaiah GM, Garber DW, White CR. Anantharamaiah GM, et al. Among authors: white cr. Protein Pept Lett. 2016;23(11):1024-1031. doi: 10.2174/0929866523666160901154216. Protein Pept Lett. 2016. PMID: 27586181

3

Apolipoprotein Mimetic Peptides: An Emerging Therapy against Diabetic Inflammation and Dyslipidemia.

Wolkowicz P, White CR, Anantharamaiah GM. Wolkowicz P, et al. Among authors: white cr. Biomolecules. 2021 Apr 23;11(5):627. doi: 10.3390/biom11050627. Biomolecules. 2021. PMID: 33922449 Free PMC article. Review.

4

Atherosclerosis and vascular disease: effects of peptide mimetics of apolipoproteins.

Garber DW, Handattu SP, Datta G, Mishra VK, Gupta H, White CR, Anantharamaiah GM. Garber DW, et al. Among authors: white cr. Curr Pharm Biotechnol. 2006 Aug;7(4):235-40. doi: 10.2174/138920106777950834. Curr Pharm Biotechnol. 2006. PMID: 16918400 Review.

5

Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats.

Zhang Z, Datta G, Zhang Y, Miller AP, Mochon P, Chen YF, Chatham J, Anantharamaiah GM, White CR. Zhang Z, et al. Among authors: white cr. Am J Physiol Heart Circ Physiol. 2009 Aug;297(2):H866-73. doi: 10.1152/ajpheart.01232.2008. Epub 2009 Jun 26. Am J Physiol Heart Circ Physiol. 2009. PMID: 19561306 Free PMC article.

6

Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH(2).

Datta G, White CR, Dashti N, Chaddha M, Palgunachari MN, Gupta H, Handattu SP, Garber DW, Anantharamaiah GM. Datta G, et al. Among authors: white cr. Atherosclerosis. 2010 Jan;208(1):134-41. doi: 10.1016/j.atherosclerosis.2009.07.019. Epub 2009 Jul 15. Atherosclerosis. 2010. PMID: 19656510 Free PMC article.

7

Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm In Hdl Therapy (Vascular Disease Prevention, In Press.).

White CR, Datta G, Mochon P, Zhang Z, Kelly O, Curcio C, Parks D, Palgunachari M, Handattu S, Gupta H, Garber DW, Anantharamaiah GM. White CR, et al. Vasc Dis Prev. 2009 Jan 1;6:122-130. doi: 10.2174/1567270000906010122. Vasc Dis Prev. 2009. PMID: 20084185 Free PMC article.

8

Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages.

Smythies LE, White CR, Maheshwari A, Palgunachari MN, Anantharamaiah GM, Chaddha M, Kurundkar AR, Datta G. Smythies LE, et al. Among authors: white cr. Am J Physiol Cell Physiol. 2010 Jun;298(6):C1538-48. doi: 10.1152/ajpcell.00467.2009. Epub 2010 Mar 10. Am J Physiol Cell Physiol. 2010. PMID: 20219948 Free PMC article.

9

ApoE mimetic peptide reduces plasma lipid hydroperoxide content with a concomitant increase in HDL paraoxonase activity.

Datta G, Chaddha M, Handattu SP, Palgunachari MN, Nayyar G, Garber DW, Gupta H, White CR, Anantharamaiah GM. Datta G, et al. Among authors: white cr. Adv Exp Med Biol. 2010;660:1-4. doi: 10.1007/978-1-60761-350-3_1. Adv Exp Med Biol. 2010. PMID: 20221865

10

The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats.

Dai L, Datta G, Zhang Z, Gupta H, Patel R, Honavar J, Modi S, Wyss JM, Palgunachari M, Anantharamaiah GM, White CR. Dai L, et al. Among authors: white cr. J Lipid Res. 2010 Sep;51(9):2695-705. doi: 10.1194/jlr.M008086. Epub 2010 May 22. J Lipid Res. 2010. PMID: 20495214 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

376 results

Search Page